Sector: Health Care
Director information for EMBECTA CORP (data for year 2025)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Bob J. Hombach | Chair | [] | [] | 2025 | |
| Carrie L. Anderson | Former Executive Vice President and Chief Financial Officer, The Campbell’s Company | 57 | ["financial expertise", "life sciences experience", "experience working with large, diversified global manufacturing companies", "executive leadership", "strategy and innovation", "risk and crisis management", "consumer/retail", "ESG", "experience with institutional investors"] | ["Audit", "Corporate Governance and Nominating"] | 2025 |
| Christopher R. Reidy | Retired Executive Vice President, Chief Administrative Officer and Chief Financial Officer, Becton, Dickinson and Company (“BD”); Chair | 69 | [] | [] | 2025 |
| Claire Pomeroy, M.D. | Chair; President of the Albert and Mary Lasker Foundation | 70 | ["expert in infectious diseases", "broad experience in healthcare delivery", "health system administration", "payer and medical reimbursement", "higher education", "medical research", "public health", "perspectives on patient care services", "global health", "health policy"] | ["Corporate Governance and Nominating", "Technology, Quality and Regulatory"] | 2025 |
| Devdatt (Dev) Kurdikar | President and Chief Executive Officer, Embecta Corp. | 57 | ["experienced healthcare executive", "extensive experience in the medical device industry", "experience with global business, operations and manufacturing", "strategy and innovation", "cybersecurity and information systems", "risk and crisis management", "ESG", "regulatory and compliance matters", "experience with institutional investors"] | ["AdvaMed", "LMG Holdings", "Zimmer Biomet Holdings, Inc."] | 2025 |
| Karen N. Prange | Industrial Advisor, EQT Group and Former Executive Vice President and Chief Executive Officer, Global Animal Health, Medical and Dental Surgical Group of Henry Schein, Inc. | 61 | ["public company governance experience", "leadership experience in the medical industry", "global business", "strategy and innovation", "payer and medical reimbursement", "risk management", "ESG", "regulatory and compliance experience"] | ["Compensation and Management Development (Chair)", "Corporate Governance and Nominating"] | 2025 |
| Milton M. Morris, Ph.D. | Former Chairman and Chief Executive Officer, Neuspera Medical, Inc. | 55 | [] | [] | 2025 |
